The global targeted protein degradation market size is projected to grow from USD 541.98 million in 2024 to USD 3547.91 million by 2034, at a CAGR of 20.7%, according to a new report by Polaris Market Research.
Targeted protein degradation assimilates the cell's organic ejection system to discard disease-generating proteins and is suitable for varied therapeutic regions involving oncology, dermatology, immunology, neuroscience, and respiratory illness. As a completely new perspective, it offers aspiration of illnesses formerly considered to be undruggable. Degrading instead of impeding a target protein provides many benefits, such as a more productive drug response at lower doses and a more accurate mediation with possibly decreased ramifications and illness aversion.
Targeted Protein Degradation Market Growing at 20.7?GR to Hit USD 3547.91 million by 2034 | PMR